Morgan Stanley began coverage on shares of Afya (NASDAQ:AFYA) in a research note published on Tuesday morning, BenzingaRatingsTable reports. The brokerage issued an overweight rating and a $29.20 price objective on the stock.
Several other equities analysts have also commented on the company. Bank of America began coverage on Afya in a research report on Tuesday. They set a buy rating and a $29.00 price objective for the company. JPMorgan Chase & Co. began coverage on Afya in a research report on Friday, August 9th. They set an overweight rating and a $34.00 price objective for the company.
Shares of Afya stock opened at $25.59 on Tuesday. Afya has a 12 month low of $22.00 and a 12 month high of $29.37.
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Featured Story: How is the discount rate different from the Federal Funds rate?
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.